Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


28.10.2024

1 BMC Neurol
1 J Clin Psychopharmacol
3 J Neural Transm (Vienna)
2 Lancet Neurol
4 Mov Disord
3 N Engl J Med
2 Neurobiol Dis
1 Neurology
1 Neuroscience
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. CHAHINE LM, Louie N, Solle J, Akcimen F, et al
    The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol.
    BMC Neurol. 2024;24:403.
    PubMed         Abstract available


    J Clin Psychopharmacol

  2. SKOBLE L, Kutz S, Friedman JH
    Myocarditis on Clozapine 50 mg/d in a Patient With Parkinson's Disease.
    J Clin Psychopharmacol. 2024 Oct 25. doi: 10.1097/JCP.0000000000001927.
    PubMed        


    J Neural Transm (Vienna)

  3. JELLINGER KA
    Behavioral disorders in Parkinson disease: current view.
    J Neural Transm (Vienna). 2024 Oct 25. doi: 10.1007/s00702-024-02846.
    PubMed         Abstract available

  4. MOES HR, Dafsari HS, Jost WH, Kovacs N, et al
    Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies.
    J Neural Transm (Vienna). 2024;131:1295-1305.
    PubMed         Abstract available

  5. ROZANKOVIC PB, Johansson A, Peter K, Milanov I, et al
    Monotherapy with infusion therapies - useful or not?
    J Neural Transm (Vienna). 2024;131:1341-1348.
    PubMed         Abstract available


    Lancet Neurol

  6. GASSER T
    The global dimension of Parkinson's disease genetics.
    Lancet Neurol. 2024 Oct 21:S1474-4422(24)00435.
    PubMed        

  7. LIM SY, Tan AH, Ahmad-Annuar A, Okubadejo NU, et al
    Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic.
    Lancet Neurol. 2024 Oct 21:S1474-4422(24)00378.
    PubMed         Abstract available


    Mov Disord

  8. HINES K, Noecker AM, Frankemolle-Gilbert AM, Liang TW, et al
    Prospective Connectomic-Based Deep Brain Stimulation Programming for Parkinson's Disease.
    Mov Disord. 2024 Oct 21. doi: 10.1002/mds.30026.
    PubMed         Abstract available

  9. AJALIN R, Al-Abdulrasul H, Tuisku JM, Hirvonen J, et al
    Impaired Gait, Postural Instability, and Rigidity in Relation to CB1 Receptor Availability in Parkinson's Disease.
    Mov Disord. 2024 Oct 22. doi: 10.1002/mds.30042.
    PubMed         Abstract available

  10. EMMI A, Macchi V, Stocco E, Tushevski A, et al
    alpha-Synuclein Pathology in the Carotid Body: Experimental Evidence for a possible Contributor to Respiratory Impairment in Parkinson's Disease.
    Mov Disord. 2024 Oct 24. doi: 10.1002/mds.30036.
    PubMed        

  11. MAHAJAN A, Morrow CB, Seemiller J, Mills KA, et al
    The Effect of Dysautonomia on Motor, Behavioral, and Cognitive Fluctuations in Parkinson's Disease.
    Mov Disord. 2024 Oct 25. doi: 10.1002/mds.30044.
    PubMed         Abstract available


    N Engl J Med

  12. TANNER CM, Ostrem JL
    Parkinson's Disease. Reply.
    N Engl J Med. 2024;391:1559.
    PubMed        

  13. OLSON KR
    Parkinson's Disease.
    N Engl J Med. 2024;391:1558-1559.
    PubMed        

  14. BEUCLER N
    Parkinson's Disease.
    N Engl J Med. 2024;391:1558.
    PubMed        


    Neurobiol Dis

  15. CARRILLO F, Palomba NP, Ghirimoldi M, Dido C, et al
    Multiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.
    Neurobiol Dis. 2024 Oct 18:106698. doi: 10.1016/j.nbd.2024.106698.
    PubMed         Abstract available

  16. CAO C, Litvak V, Zhan S, Liu W, et al
    Low-beta versus high-beta band cortico-subcortical coherence in movement inhibition and expectation.
    Neurobiol Dis. 2024;201:106689.
    PubMed         Abstract available


    Neurology


  17. Author Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries.
    Neurology. 2024;103:e210092.
    PubMed        


    Neuroscience

  18. LEE HM, Lee DH, Lee HG, Kwon S, et al
    Functional neural substrates of Parkinson's disease and potential underpinnings of acute responses to acupuncture stimulation.
    Neuroscience. 2024 Oct 22:S0306-4522(24)00534.
    PubMed         Abstract available


    PLoS One

  19. SAIBENE FL, Agliardi C, Salvatore A, Arcuri P, et al
    Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.
    PLoS One. 2024;19:e0309405.
    PubMed         Abstract available

  20. NOMOTO M, Tsuboi Y, Kashihara K, Chiu SW, et al
    Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST.
    PLoS One. 2024;19:e0309297.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.